EVANSTON, Ill., Feb. 19, 2020 (GLOBE NEWSWIRE) — Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the […]
WESTPORT, Feb. 19, 2020 (GLOBE NEWSWIRE) —Commercialization and install plan ahead of scheduleInstallations at new centers are driving patient enrollments […]
WESTLAKE VILLAGE, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on […]